IL22 and pancreas disorder: Importantly, IL-22 treatment downregulated expression of key genes involved in disease pathways including endocrine pancreatic dysfunction, Diabetes mellitus, severe pancreatic disorders, and impaired glucose tolerance (Supplementary Fig. 2c).